The invention relates to the field of surgical procedures, during which a fluid is delivered to a patient and, in most cases, simultaneously drained from the patient. A particular application of the invention is found in hyperthermic intra-peritoneal chemotherapy (HIPEC), during which a heated fluid containing chemotherapy drugs is pumped into the abdominal cavity of a patient. However, the invention has wider applications in the delivery of fluids to a patient during surgical or other medical procedures, especially when the fluids require a preparation step such as heating prior to delivery.
The fluid is typically based on saline. It need not contain a drug or other biologically active ingredient: it could be used purely to maintain fluid pressure or hydration in the patient. Alternatively, the fluid could be a bodily fluid such as blood or plasma that is first removed from the patient, treated and then recirculated back to the patient.
The patient may be human or animal.
HIPEC is a procedure that is used following surgery to remove cancerous tumours from inside the abdominal (or peritoneal) cavity. In order to kill cancerous cells that might remain, a heated saline solution containing one or more chemotherapy drugs is pumped into the peritoneal cavity to bathe the abdominal organs for a period of time: normally at least 45 to 90 minutes. By heating the fluid above ambient temperature, e.g. to 42° C., the efficacy of the chemotherapy drugs is increased. Dedicated apparatus is provided for, in a recirculation mode, pre-treating the fluid by using a pump to circulate the fluid through a heated reservoir until it reaches the required temperature; then, in a delivery mode, pumping the pre-treated fluid into the abdominal cavity of the patient.
There are two variants of the HIPEC procedure. In closed HIPEC, at the end of the surgery a delivery tube and a return tube are inserted into the abdominal cavity and the main incision is stitched to close the cavity and substantially seal around those tubes. The HIPEC apparatus then pumps fluid into the cavity through the delivery tube. When the cavity is full, continued pumping causes the excess fluid to return to the apparatus via the return tube, owing to the internal pressure in the cavity. In open HIPEC, at the end of the surgery a delivery tube and a return tube are inserted into the abdominal cavity, which is left open. The HIPEC apparatus then pumps fluid into the cavity through the delivery tube. The apparatus simultaneously pumps excess fluid out of the cavity to return to the apparatus via the return tube. One advantage of open HIPEC is that the surgeon continues to have access to the abdominal cavity during the HIPEC process and can manipulate the abdominal organs to ensure that the fluid reaches all parts of them. A disadvantage is that it requires a second pump to drain the fluid from the patient.
The known HIPEC apparatus requires manual input to switch the apparatus between the recirculation mode and the delivery mode by rotating a dial. It would be preferable for switching to be under automatic control. The apparatus should also be suitable for use in both open and closed HIPEC procedures.
Because the delivery and return tubes must be inserted into the abdominal cavity at the end of the surgical procedure, they need to be kept sterile both inside and outside, while the HIPEC apparatus generally needs to be kept sterile only on the internal surfaces that come into contact with the fluid. There is a need for a convenient and reliable method of connecting the sterile delivery and return tubes to the non-sterile HIPEC apparatus.
The invention provides a medical apparatus for delivering fluid to a patient, as defined in claim 1.
The invention further provides a method of operating medical apparatus to deliver fluid to a patient, as defined in claim 17.
A further aspect of the invention is a connector for use with fluid delivery apparatus, as defined in claim 15.
Features of the invention that are preferred but not essential are defined in the dependent claims.
One advantage of the fluid delivery apparatus of the present invention is the ease with which it can be switched from the recirculation mode to the fluid delivery mode, simply by reversing the direction of the first pump. This means that the mode can be changed automatically or under electronic control, without the need to manually turn a valve, for example.
Preferably, when the pump reverses, the valve assembly will respond to the change in pressure at the second valve port by opening one and closing the other of the first and second valves to direct fluid flow in the appropriate manner. However, the invention in its broadest scope does not exclude other means of achieving the same result, such as operating the valves under automatic control or replacing the first and second valves with a single, three-way valve.
The invention further provides a connector for connecting a fluid delivery tube to a fluid delivery apparatus, the connector comprising a through bore extending from a first end of the connector to a second end of the connector; a first coupling at the first end for attaching the connector to a flexible tube; and a second coupling at the second end for non-removably attaching the connector to the third valve port.
A first side wall of the reservoir 2 is moulded with an arcuate recess that forms a track 8 for a first peristaltic pump 10. Near the ends of the arcuate recess, the first side wall is penetrated by first and second pump ports 14,15. The opposite, second side wall of the reservoir 2 is similarly moulded with an arcuate recess that forms a track 9 for a second peristaltic pump 12, and is penetrated by third and fourth pump ports 16,17. The first and second pump ports 14,15 are connected to one another by a first compressible tube 18 that runs around the track 8 of the first peristaltic pump 10. In a well known manner, the first peristaltic pump 10 comprises a hub that is mounted for rotation about a horizontal axis and supports a set of rollers about its circumference. The rollers in one sector of the circumference compress the tube against the track 8, trapping portions of fluid in the uncompressed lengths of tube between them. By rotating the hub, the rollers are caused to move around the track and force the portions of fluid to move with them. The direction of the first pump 10 is reversible so that it can be operated to pump fluid from the first pump port 14 to the second pump port 15 or vice versa. The second peristaltic pump 12 is configured in an identical manner to pump fluid between the third and fourth pump ports 16,17 via a second compressible tube 19, although for the purpose of the present invention it is not essential that the second pump 12 should be reversible.
A heating panel 20 is provided in the base of the reservoir 2. A temperature probe 21 is provided within the reservoir 2 and adjacent to the second pump port 15 to measure the temperature of fluid as it emerges from the second pump port 15.
A valve assembly 22 is supported by the cover 4 of the reservoir 2. Details of the valve assembly 22 are shown in the cut-away view of
The first valve port 28 opens between the first valve chamber 24 and the interior of the reservoir 2. It is coupled to the upper end of an intake tube 32, the lower end of which opens into the reservoir 2 below the expected fluid level.
The second valve port 29 opens between the second valve chamber 25 and the interior of the reservoir 2. It is coupled to the upper end of a first transfer tube 34, the lower end of which is coupled to the first pump port 14, whereby the first transfer tube 34 passes through the interior of the reservoir 2 but fluid contained within the first transfer tube 34 remains separate from the bulk fluid in the reservoir 2.
The third valve port 30 opens between the third valve chamber 26 and the exterior of the reservoir 2. During use of the apparatus it is coupled to the proximal end of a delivery tube 36 for delivery of fluid to a patient, as described below.
The first and second valve chambers 24,25 are connected via a first valve 38, which permits fluid to flow from the first valve chamber 24 to the second valve chamber 25 but not in the opposite direction. The second and third valve chambers 25,26 are connected via a second valve 40, which permits fluid to flow from the second valve chamber 25 to the third valve chamber 26 but not in the opposite direction. There is no direct connection between the first and third valve chambers 24,26. In the preferred embodiment of the invention the valves 38,40 are umbrella valves but other types of one-way valve would be acceptable alternatives.
A filter assembly 42 is also supported by the cover 4 of the reservoir 2. The filter assembly 42 comprises a tray that is divided into a suction chamber 44 and a filter chamber 46. There is no direct communication between the suction chamber 44 and the filter chamber 46 so they could alternatively be formed as separate components.
The suction chamber 44 is airtight, except for a suction return port 48 and a suction outlet port 50. The suction return port 48 opens to the exterior of the reservoir 2. During certain uses of the apparatus it may be coupled to the proximal end of a suction return tube 52 for receiving fluid from a patient, as described below. The suction outlet port 50 opens to the interior of the reservoir 2. It is coupled to the upper end of a second transfer tube 54, the lower end of which is coupled to the third pump port 16, whereby the second transfer tube 54 passes through the interior of the reservoir 2 but fluid contained within the second transfer tube 54 remains separate from the bulk fluid in the reservoir 2.
The filter chamber 46 comprises a gravity return port 56, a filter inlet port 58 (hidden from view in
Ignoring the presence of any keyways, as just discussed, the port 72 consists of a simple, cylindrical collar 74 that extends through a wall 76 of the apparatus and is open at both ends. The connector 70 is essentially a smaller cylinder that fits snugly through the collar 74 of the port 72. An O-ring 78 is seated in an outward-facing circumferential channel of the connector 70 to seal between the connector 70 and the port 72. A flange 80 projects radially from the connector 70 so that when the connector 70 is inserted into the port 72, the flange 80 butts against the outer end of the collar 74 and prevents the connector 70 being inserted further. The proximal end of the connector 70 is divided by slots into a number of longitudinal arms 82. In the illustrated embodiment, the number of arms 82 is four. Each of the arms 82 ends in an outwardly-projecting tang 84, which has a radius greater than the internal radius of the collar 74 such that, as the connector 70 is inserted into the port 70, the tangs 84 force the arms to bend inwards to fit through the collar 74. Preferably the outer surfaces of the tangs 84 are tapered to facilitate inserting them into the collar 74. Just before the flange 80 comes into contact with the distal end of the collar 74, the tangs pass the proximal end of the collar 74, thereby allowing the resilient arms 82 to spring outwards and the tangs 84 to form a snap-fit engagement with the proximal end of the collar 74, as seen in
Because the distal end of the flexible tube is generally implanted into the patient during surgery, the tube and its attached connector 70 need to be kept sterile, while the external surfaces of the fluid delivery apparatus are typically not sterile. For this reason, the connector 70 is first attached to the tube and remains with it during sterilization and surgery. When the fluid delivery apparatus is needed, it is brought into the non-sterile area of the operating theatre and the tube is then connected to it by inserting the connector 70 into the port 72 as just described. When doing that, the operator grips the outside of the tube in the region of the barb 86 and there is no need for them to touch the port 72 or any other part of the unsterilized apparatus. Until the connectors 70 are attached, the external ports of the apparatus are preferably closed by removable caps (not shown) to prevent contamination of the interior of the apparatus.
The recirculation mode of operation is used to prepare the fluid for delivery to the patient, in particular by pre-heating it to the desired temperature for the HIPEC procedure. A suitable volume of saline fluid is first delivered from a supply 88 into the reservoir 2 and the heater 20 is switched on to warm the fluid at the base of reservoir. Although the heat will spread through the fluid by conduction and convection, it can be brought to a more uniform temperature by using the first pump 10 to recirculate the fluid. The pump 10 is operated in a first direction (shown as clockwise in
The temperature probe 21 monitors the temperature of the fluid as it emerges from the second pump port 15 and sends measurements to a controller (not shown) that can display the information to a human operator and/or use the information for automatic control of the heater 20 and the first pump 10. The controller may also be used for manual and/or automatic control of the second pump 12, the supplies of saline 88 and chemotherapy drugs 89 and any other aspects of the apparatus. For this purpose it may receive signals from other sensors (not shown), e.g. to monitor the temperature of the fluid at different locations, or the condition of the fluid returning from a patient.
In this mode, the first pump 10 is operated in the direction (shown as anti-clockwise in
At some stage, the supply 89 of chemotherapy drugs is turned on to add those drugs to the fluid in the reservoir, from where the saline fluid can carry them to the patient. The apparatus is capable of introducing the chemotherapy drugs after the circulation shown in
The apparatus is further provided with a waste tank 94 coupled to the delivery tube 36 by a discharge tube 92. A valve (not shown) may be operated by the controller to divert circulating fluid into the waste tank 94, for example in the event that there is excess fluid in the system or the fluid needs to be refreshed with clean fluid from the supply 88.
The heater 20 may continue to operate during the delivery mode of the apparatus, in order to replace heat lost by the fluid as it circulates via the patient. It may be operated at selective times or at a power level determined in response to signals from the temperature sensor 21, which can monitor the temperature of the fluid entering the second pump port 15, or signals from other temperature sensors (not shown), e.g. for monitoring the temperature of fluid as it passes through the body cavity of the patient or when it returns to the reservoir.
The first pump 10 and the valve assembly 22 operate in just the same manner as with closed HIPEC, described above with reference to
The second pump 12 is operated in a direction (shown as anti-clockwise in
The reader will understand that it is not essential for the fluid paths to be exactly as described in relation to the illustrated embodiment of the invention. For example, the first, second and third transfer tubes pass through the interior of the reservoir 2 only because they need to connect respectively to the first, third and fourth pump ports 14,16,17. Although this keeps the tubes neatly contained within the apparatus, a different physical arrangement could be without changing the essential features of the fluid circuit.
It is not excluded that the apparatus could be set up and operated as described in relation to
Number | Date | Country | Kind |
---|---|---|---|
1919087.5 | Dec 2019 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2020/086705 | 12/17/2020 | WO |